KATs in the MYST: A New Therapeutic Vulnerability for SETBP1-Mutated Myeloid Malignancies

Mark Soto1,2, Kira Gritsman1,2,3

  • 1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York.